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Summary 
A  novel recombinant histamine-releasing factor (rHFR),  which  stimulates  secretion from a 
subpopulation of human basophils that express a particular type of immunoglobuhn E  (IgE) or 
IgE +, was found to induce interleukin-4 (IL-4) production from cells isolated from these same 
donors. The secretion of IL-4 protein induced by rHRF significantly correlated with histamine 
release and the amount of protein generated, and the kinetics were identical to those caused by 
anti-IgE activation. Furthermore, the ability of rHRF to induce IL-4 protein production from 
cells not normally responsive to this protein was transferred by passive sensitization with plasma 
containing IgE + antibody. That this novel protein stimulates both mediator release and the se- 
cretion of IL-4 protein from human basophils suggests a prominent role for this molecule in al- 
lergic disease. 
H 
uman basophils  release potent inflammatory media- 
tors,  such  as  histamine  and  leukotriene  C4,  in  re- 
sponse to a variety of stimuli both related and unrelated to 
antigen cross-linking of IgE/receptor complexes. Work in 
our laboratory using antigen challenge models, and that in a 
variety of other laboratories using biopsy and autopsy mate- 
rial from asthmatics, suggests that basophils infiltrate the tissue 
and play an important role in the pathogenesis of chronic 
allergic lesions (1-4). This concept is supported by recent 
studies showing that basophils generate and secrete high levels 
of IL-4 (5-8), a proinflammatory cytokine having immu- 
noregnlatory properties that affect many different cell types 
that infiltrate during allergic inflammation. The secretion of 
IL-4 protein, however, unlike that described for histamine 
release, seems more dependent on signals  generated in re- 
sponse  to  IgE-dependent stimulation  (8),  with  little  evi- 
dence thus far that other physiologic stimuli can similarly 
activate the basophil to induce secretion of this cytokine. 
Among basophil secretogognes, a  considerable amount 
of attention has been directed to a group of  proteins collec- 
tively referred to as histamine releasing factors (HRFs). The 
HRFs are generated by a number of different cell types, in- 
cluding monocytes (9),  B  cells  (10), platelets (11-13), and 
endothelial cells  (10).  HRFs are felt to play a role in the 
pathogenesis  of chronic  allergic  inflammation,  a  concept 
supported by the fact that these substances can be recovered 
from cutaneous,  bronchoalveolar, and  nasal lavage fluids. 
Two types of HRFs have been described: those that induce 
histamine  release in  a  reaction requiting cell  surface IgE, 
and those that operate independently of IgE antibody. The 
IgE-independent activity is linked to a growing hst of re- 
combinant cytokines, the  chemokines,  that  induce  hista- 
mine release from basophils in addition to having chemo- 
tactic activity for a variety of cells. Of the chemokines tested, 
monocyte chemotactic protein-1 (MCP-1) and MCP-3 are 
the most potent activators of basophils, inducing mediator 
release at nanomolar concentrations (14).  The IgE-depen- 
dent HRFs, described as causing histamine release from cells 
expressing a particular type of IgE (designated as IgE+), had 
only been partially characterized (15).  Recently, however, 
a  cDNA clone that codes for a protein with a molecular 
weight of 23,000 daltons has been subcloned and expressed. 
This human recombinant protein, rp23, and its murine ho- 
mologue, rp21,  have the same  IgE-dependent histamine- 
releasing activity as the previously described HRF found in 
vivo (16). 
In the present study, we investigate the ability of these 
recombinant molecules to induce IL-4 secretion from hu- 
man basophils, since IgE-dependent activation is an impor- 
tant  stimulus  for the  generation of this  cytokine message 
and  protein.  Our  results  show  that  rp21  and  rp23  are 
equally effective at promoting the secretion of IL-4 protein 
from basophils that release histamine in response to these 
recombinant proteins, with production dependent on the 
expression oflgE  +. The IgE-independent HRF and MCP-3, 
and the cytokine, interleukin-3 (IL-3), do not appear to have 
the same IL-4--inducing capabilities associated with rp23/ 
rp21. We hypothesize that this IgE-dependent HRF plays a 
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ing both  histamine release  and  IL-4  secretion  from  baso- 
phils in vivo. 
Materials  and Methods 
Buffers and Media.  10  ￿  Pipes contained 250 mM Pipes, 110 
mM NaC1, and 50 mM KC1, pH 7.4. A  Pipes/albumin/glucose 
buffer (PAG) contained 0.1 10 ￿  Pipes in addition to 0.003% hu- 
man serum albumin (HSA)  (Calbiochem-Bering Corp., La Jolla, 
CA) and 0.1% D-glucose. PAG-EDTA additionally contained 4 
mM EDTA.  Isotonic Percoll (referred to as  100% Percoll) con- 
sisted of 1 part  10  ￿  Pipes and 9 parts Percoll (Pharmacia Bio- 
tech, Piscataway, NJ).  Percoll solutions of 55%  (d =  1.072)  and 
65% (d =  1.083) were made by mixing the appropriate amounts 
of 1 ￿  Pipes and 100% Percoll. Conditioned IMDM (C-IMDM) 
consisted of IMDM containing 5% heat-inactivated (56~  for 30 
min) FBS (Sigma Chemical Co., St. Louis, MO),  1 ￿  nonessen- 
tial amino acids,  and 5 p,g/ml gentamicin. 
Special Reagents.  Recombinant IL-3 (rhlL-3) was a kind gift 
from Dr. S. Gillis (lmmunex Corporation, Seattle, WA). MCP-1 
was  purchased from  Pepro  Tech  (Rocky  Hill,  NJ).  Polyclonal 
anti-human IgE antibody was generated in a goat and affinity pu- 
tiffed. 
Preparation of Recombinant HRF.  The cDNA for rp21 was kindly 
supplied by Drs. M. Koots and G. Brawerman of Tufts University 
(Boston, MA). Primers were designed, and the PCR product was 
expressed  in  Escherichia coli as  a  protein  fused  to  glutathione 
S-transferase  (GST)  and affinity purified on immobilized gluta- 
thione. The same primers were used to generate the human rp23 
from the U937 cell line. This was also expressed as a GST fusion 
protein  and affinity purified.  Since we  have  previously shown 
that both rp21 and rp23 induced similar IgE-dependent histamine 
release (16),  we have used both of these recombinant proteins in 
this article. The concentration of recombinant HRF used in these 
studies was 8 I.tg/ml, or ~4  ￿  10 -7 M. 
Basophil Preparation.  Venous blood from consenting donors was 
anticoagulated with  10  mM  EDTA.  Whole  blood  was  centri- 
fuged at 300 g, and the leukocyte interface (buffy-coat) was aspirated 
and transferred to PAG-EDTA (1 : 1 vol/vol). Basophil-enriched 
suspensions were  prepared  by Percoll density centrifugation, as 
previously described (8).  In brief, the diluted buffy-coat suspen- 
sion was layered onto gradients consisting of 12 mi of 55% Percoll 
layered onto 12 ml of 65% Percoll in clear 50 ml polypropylene 
tubes.  Percoll gradients were centrifuged at 700 g  for 20 rain at 
room temperature. Cells banding at the 55% Percoll interface and 
penetrating the top half of this layer were removed and discarded. 
Basophils were in the fraction consisting of the lower half of the 
55% Percoll, the 65% interface, and the upper half of this layer. 
Cells in this fraction were washed twice in PAG-EDTA followed 
by a  final wash in cold  (4~  PAG. Basophils were  counted in 
Spiers-Levy chambers using Alcian blue (17).  The purity of the 
basophils  in the  cell  suspensions used  for  these  studies  ranged 
from 5%} to 40%. 
Passive Sensitization of Basophils.  For  some  experiments,  sur- 
face IgE was removed from a portion of Percoll-isolated basophils 
by lactic acid treatment (18). Basophils were then passively sensi- 
tized with IgE  (2-8 p,g/ml) from the serum of one of two pa- 
tients responsive to IgE-dependent HRF (IgE+). For controls, a 
set of acid-treated cells were sensitized with an equal concentra- 
tion of normal polyclonal IgE  or myeloma IgE  (IgE-)  or were 
simply left unsensitized. 
Culture Conditions.  Cultures were performed in C-IMDM with 
96-well microtiter plates (Costar Corp., Cambridge, MA), as pre- 
viously described (8).  The number of basophils cultured ranged 
from 50,000 to 200,000 per well. For most experiments, the cells 
were added to culture wells in 125 p~l of medium and brought to 
37~  in a CO2 incubator (5% CO2) before adding an equal vol- 
ume  of medium  (preeqnilibrated in  the  incubator)  containing 
twice the final concentration of stimulus. Atier 1-6 h of incubation, 
cell-free culture supernatants were  harvested and centrifuged at 
150 g at 4~  and the supernatant was removed for histamine and 
IL-4 protein analysis by automated fluorometry and ELISA, re- 
spectively (8). In some instances, IL-4 protein was measured by a 
commercial ultrasensitive ELISA (sensitivity, < 1 pg/ml), accord- 
ing to the manufacturer's protocol (BioSource International, Ca- 
marillo, CA). 
Results 
Induction  of lL-4  Secretion by Recombinant HRF  Correlates 
with Histamine Release.  Basophils generate IL-4 in response 
to anti-IgE at concentrations nearly 10-fold less than those 
required for optimal histamine release (8).  However, as shown 
in  Fig.  1,  the  generation  of IL-4  significantly  correlated 
with maximal histamine release  (r =  0.90, p  =  0.001,  n  = 
14).  Of the  donors previously shown to  release  histamine 
in  response  to  the  native  HRF,  all  generated  detectable 
amounts  of IL-4  when  challenged  with  the  recombinant 
HRF,  with  protein levels ranging from  40  to  470  pg per 
106  basophils.  In contrast,  in five donors who  did not re- 
lease histamine in response to the native HRF, but who are 
known  to  secrete  IL-4  in  response  to  anti-IgE  antibody, 
rp21  or rp23 failed to induce IL-4 generation. 
Time  Course  of IL-4  Secretion by Basophils  Induced  by Re- 
combinant HRF,  Previous studies have shown that the na- 
tive  IgE-dependent  HRF  induces  histamine  release  from 
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Figure 1.  The secretion oflL-4 protein from basophils challenged with 
recombinant HRF significantly correlates with histamine release. Baso- 
phils from 14 donors were prepared as described in Materials and Meth- 
ods. Cultures were challenged with rp21 (8 p~g/ml) or rp23 (7.5 b~g/ml) 
for 4 h before harvesting cell-free supematants for histamine and IL-4 
protein measurements. The secretion of IL-4 significantly correlated (r = 
0.90, p  =  0.001) with histamine release, as determined  by Spearman's 
rank correlation coefficient. 
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duced by anti-IgE stimulation (15). We  compared the ki- 
netics of IL-4 secretion by basophils stimulated with anti- 
IgE antibody or with the recombinant HRF. In Fig. 2, the 
time course of the generation of IL-4 induced by rp21  or 
rp23 was identical to that caused by anti-IgE activation (a). 
With both  stimuli, protein was  first detected after  1  h  of 
culture, with levels peaking by 4  h; no  additional increase 
was observed at 6 h. Also shown in this figure, for compar- 
ison, are the kinetics of histamine release (b). Although the 
responses induced by recombinant protein were rapid and 
generally peaked by 60-90 min, histamine release was slightly 
faster  for  anti-IgE  stimulation,  particularly  at  the  earlier 
(<60 rain) time points. 
Transfer of Releasability with Passive Sensitization.  For the 
next series of experiments, we isolated basophils from nor- 
mal donors who did not release histamine, or secrete IL-4, 
in response to rp21 or rp23. A portion of these cells was left 
untreated;  surface IgE was partially removed from the re- 
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Figure 2.  Time course of IL-4 protein secretion and histamine release 
induced by recombinant HRF. Basophils from three donors were pre- 
pared as described in Materials and Methods. Cell cultures were  chal- 
lenged with either rp21 (8 I.~g/ml)  or with rp23 (7.5 p.g/ml) for the indi- 
cated times, before harvesting cell-free supernatants for IL-4 protein (a) 
and histamine (b) measurements. 
maining  cells by  lactic  acid  treatment  (see  Materials  and 
Methods).  Half of the  cells treated  with  lactic acid were 
passively sensitized with IgE from the serum of a patient re- 
sponsive to the HRF  in an attempt to transfer reactivity to 
normal cells. As a control, the other portion of the treated 
cells was passively sensitized with an equal concentration of 
polyclonal serum IgE from a  normal patient, or with my- 
eloma IgE. As shown in Fig. 3, cells left untreated and those 
passively sensitized with both forms of IgE secreted IL-4 in 
response to anti-IgE antibody (a). These  cells also released 
histamine in response to anti-IgE (b).  However, IL-4 pro- 
tein and histamine were secreted in response to recombinant 
HRF  only by cells that were passively sensitized with IgE  § 
Secretion of lL-4 Protein by Basophils Induced by Recombinant 
HRF versus That Caused by Other Secretogogues.  In a final se- 
ries of experiments, we compared IL-4 secretion and hista- 
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Figure 3.  Basophil  releasability  to recombinant HRF protein transfers 
during passive sensitization with  IgE  +. Basophil suspensions were  pre- 
pared from four donors not normally releasing to HRF. After removal of 
IgE from a portion of cells with lactic acid treatment (see Materials and 
Methods), basophils were  passively sensitized with  2-8  Ixg/ml of lgE 
from the plasma of one of two patients responsive to HRF (i.e., IgE  +) or 
with an equal concentration of either myeloma or normal polyclonal IgE 
(i.e., IgE-). As an added control, a portion of cells from each suspension 
was left untreated (unsensitized). Cells were washed before culturing for 
4 h with anti-IgE antibody (10 ng/ml) or with recombinant HRF (8 p~g/ 
n-d). Cell-free supernatants were analyzed for IL-4 protein (a) and hista- 
mine content (b). 
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HRF, with that generated in response to the IgE-indepen- 
dent HRFs, including IL-3 and MCP-1. As shown in Fig. 
4,  rp21  or rp23  caused IL-4 secretion from basophils iso- 
lated from all donors who had reacted to the native HRF. 
Nearly identical  amounts  of protein were also secreted in 
response to an optimal concentration of anti-IgE antibody 
(a).  However, the amounts of IL-4 induced by both anti- 
IgE  (10  ng/ml)  and  recombinant  HRF  were  statistically 
different from those released in response to rhlL-3  (1-100 
ng/ml)  (p  =  0.05  and p  =  0.02,  respectively). There was 
also  significantly less IL-4 protein generated in response to 
MCP-1  (10-7-10 -9 M)  compared with  the  other stimuli. 
Figure 4.  Comparison  of 1L-4 protein secretion induced by recombi- 
nant HRF, anti-lgE, rhlL-3, and MCP-1. Basophil  suspensions were pre- 
pared as described in Materials and Methods. Cell cultures were chal- 
lenged with anti-lgE (10 ng/ml), recombinant  HRF (8 ~g/ml, or ~4 ￿ 
10 -v M), rhlL-3 (1-100 ng/ml), or MCP-1 (10-~-10  -9 M). After a 4-h 
culture, cell-free  supernatants were analyzed  for IL-4  protein (a) and his- 
tamine content (b). Statistical analysis  was performed  with the Wilcoxon 
nonparametric method. 
However, with  the  exception of anti-lgE antibody versus 
MCP-1,  there  were  no  significant  differences  (p  ~<0.05) 
among  the  percentages  of histamine  released,  indicating 
that all the secretogogues were active (b). 
Discussion 
Several studies have shown that basophils infiltrate aller- 
gic lesions in the nose, lung, and skin in response to admin- 
istered  antigen  (1-3)  in  a  reaction  referred  to  as  the  late 
phase response. Lavage samples taken from similar reaction 
sites  have also  been shown  to  cause IgE-dependent hista- 
mine release from basophils in vitro (15,  19).  We have re- 
cently reported the  subcloning  and  characterization  of an 
HRF thought to represent a unique cytokine, showing no 
homology with any known interleukin, chemokine, allergen, 
or antigen, yet having the same IgE dependency as that found 
in vivo (16).  In the present study, both human (rp23)  and 
murine (rp21) recombinant forms of this protein were also 
found to induce  the  secretion of IL-4 protein from baso- 
phils, with levels identical to those caused by anti-IgE and 
peaking by 4-6 h, a time fitting with the course of the late 
phase  response.  The  activity  of  IL-4  protein  has  been 
linked to several immunoregulatory functions important in 
allergic inflammation, including  the synthesis of IgE by B 
cells (20), adherence and selective transmigration ofeosino- 
phils  on  endothelium  (21,  22),  and  the  development  of 
Th2  lymphocytes  (23).  The  fact  that  the  IgE-dependent 
HRF stimulates basophils to produce  IL-4 underscores its 
importance in  allergic disease.  In this context,  it has been 
shown that children with food sensitivity and severe atopic 
dermatitis  have lymphocytes that  generate  an  IgE-depen- 
dent  HRF  and  have basophils  that  spontaneously  release 
histarmne, with both activities disappearing when the rela- 
tive  food  is  withdrawn  (24).  It  is  not  clear  at  this  time 
whether the HRF described in these children is identical to 
the recombinant proteins tested in the present study or is a 
member of a family of IgE-dependent HRFs. 
In this manuscript, we present evidence that a significant 
correlation  exists between  histamine  release and  cytokine 
secretion induced  by rHRF,  and that the  kinetics of IL-4 
release are identical to those induced by anti-IgE antibody. 
As originally described for native HRF, basophil releasabil- 
ity to rHRF is very much dependent on the expression of a 
particular type of IgE (designated as IgE+), which is almost 
entirely  restricted  to  atopic  subjects  (15).  Cells  not  nor- 
really responsive  to  the  IgE-dependent  HRF,  when  pas- 
sively sensitized with serum containing IgE  +, do, upon ac- 
tivation with recombinant protein,  secrete both histamine 
and IL-4 protein (see  Fig.  3).  The exact nature for the in- 
teraction between the  HRF and  IgE antibodies  is not yet 
fully understood, but has sparked a number of hypotheses. 
First, the possibility that recombinant HRF represents a novel 
allergen  or  antigen  cannot be  absolutely  excluded  at  this 
time, despite the fact that it shows no homology with any 
known allergen or antigen. We have reported that PBMCs, 
from donors  both  responsive  and  unresponsive  to  HRF, 
1268  A Recombinant HRF That Induces Secretion from Human Basophils express  mRNA  for this protein  (as determined  by reverse 
transcriprion-PCR).  Thus, it seems that a protein as ubiq- 
uitous as HRF,  if truly acting as an allergen,  may, in fact, 
represent  an  autoanrigen.  In this  instance,  allergic  inflam- 
marion might then be considered an autoimmune disorder. 
Second, an early thought suggested that differences in post- 
translational  modifications  of IgE  antibody  might  be  re- 
sponsible for IgE heterogeneity,  with  HRF possibly bind- 
ing to glycosylated species  (25).  While  this hypothesis has 
not been proven incorrect, it seems unlikely in light of evi- 
dence  showing that  there  appear  to be  no lectin-binding 
sites in the recombinant HRF. However, there is now good 
evidence for altemarive  splicing within  the e  DNA locus, 
which  results  in  several  different  species  of IgE  mRNA 
(26). Therefore, as a third possibility, it seems that the IgE- 
dependent  HRF could preferentially bind to one or more 
of the antibody proteins  derived from these  transcripts.  In 
collaboration with Dr.  A.  Saxon, we  are  currently testing 
this  hypothesis.  Finally,  the  IgE-dependent  HRF  may 
function by binding to a cell surface receptor that is part of, 
or closely associated with,  FceRI, such that the binding of 
HRF  to basophils  also  expressing sufficient levels of IgE  + 
triggers signals resulting in the release of histamine and the 
secretion of IL-4 protein. Whichever one of these hypoth- 
eses  is  correct,  the  fact that  his novel protein  causes both 
the release of potent inflammatory mediators and the secre- 
tion of IL-4 protein from basophils suggests that it plays a 
significant role in allergic inflammation. 
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